Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Shock. 2014 Jan;41(1):33–39. doi: 10.1097/SHK.0000000000000067

Table 3.

Number of patients in each group receiving low-molecular weight heparin (LMWH) and aspirin (ASA), the dose given, and reason for holding doses if indicated.

Day 1 Day 2 Day 3 Day 4 Day 5
 Control (n=25)
LMWH Dose-1
 5000 Units 25 (100%) 23 (92%) 21 (84%) 21 (84%) 23 (92%)
Dose Held for RF > 1.4 0 (0%) 1 (4%) 0 (0%) 1 (4%) 0 (0%)
Dose Held Procedure 0 (0%) 1 (4%) 4 (16%) 3 (12%) 2 (8%)
 TEG-Guided (n=25)
LMWH Dose 1
 5000 Units 25 (100%) 24 (96%) 22 (88%) 19 (76%) 17 (68%)
LMWH Dose 2
 2500 Units 2 (8%) 12 (48%) 4 (16%) 2 (8%) 1 (4%)
 5000 Units 0 (0%) 0 (0%) 0 (0%) 15 (60%) 13 (52%)
ASA
 81 mg 0 (0%) 0 (0%) 0 (0%) 2 (8%) 5 (20%)
 162 mg 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%)
 325 mg 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Dose Held for RF > 1.4 0 (0%) 1 (4%) 2 (8%) 0 (0%) 2 (8%)
Dose Held Procedure 0 (0%) 0 (0%) 1 (4%) 6 (24%) 6 (24%)